“Moderna” company announced the successful results of the second phase of skin cancer vaccine test. The first results from the advanced test of the technology based...
In a phase I clinical trial, the new experimental HIV vaccine-induced broad-spectrum neutralizing antibody precursors in 97 percent of participants. The findings of a human trial...